These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33093652)

  • 61. Hippocampal Stratum Oriens Somatostatin-Positive Cells Undergo CB1-Dependent Long-Term Potentiation and Express Endocannabinoid Biosynthetic Enzymes.
    Friend LN; Williamson RC; Merrill CB; Newton ST; Christensen MT; Petersen J; Wu B; Ostlund I; Edwards JG
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987110
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models.
    Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT
    J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes.
    Yasuo S; Koch M; Schmidt H; Ziebell S; Bojunga J; Geisslinger G; Korf HW
    Cell Tissue Res; 2010 Apr; 340(1):127-36. PubMed ID: 20165884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
    Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
    Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
    Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
    Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
    Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
    Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
    Du H; Chen X; Zhang J; Chen C
    Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice.
    Gianessi CA; Groman SM; Taylor JR
    Eur J Neurosci; 2022 Feb; 55(4):922-938. PubMed ID: 33506530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
    Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.
    Szabo B; Urbanski MJ; Bisogno T; Di Marzo V; Mendiguren A; Baer WU; Freiman I
    J Physiol; 2006 Nov; 577(Pt 1):263-80. PubMed ID: 16973696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus.
    Yoshida T; Uchigashima M; Yamasaki M; Katona I; Yamazaki M; Sakimura K; Kano M; Yoshioka M; Watanabe M
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):3059-64. PubMed ID: 21282604
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain.
    Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R
    J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
    Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
    Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
    Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
    Bajo M; Roberto M; Schweitzer P
    J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice.
    Xu W; Li H; Wang L; Zhang J; Liu C; Wan X; Liu X; Hu Y; Fang Q; Xiao Y; Bu Q; Wang H; Tian J; Zhao Y; Cen X
    Nat Commun; 2020 Nov; 11(1):5962. PubMed ID: 33235205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.